Patient-reported outcomes in the phase 3 CARTITUDE-4 study of ciltacabtagene autoleucel vs standard of care in patients with lenalidomide-refractory multiple myeloma after 1-3 lines of therapy Meeting Abstract
| Authors: | Mina, R.; Mylin, A. K.; Yokoyama, H.; Magen, H.; Alsdorf, W.; Minnema, M. C.; Shune, L.; Isufi, I.; Harrison, S. J.; Shah, U. A.; Schecter, J. M.; Lendvai, N.; Gries, K. S.; Katz, E. G.; Slaughter, A.; Lonardi, C.; Gilbert, J.; Li, Q.; Deraedt, W.; Costa, O.; Patel, N.; Karlin, L.; Weisel, K. |
| Abstract Title: | Patient-reported outcomes in the phase 3 CARTITUDE-4 study of ciltacabtagene autoleucel vs standard of care in patients with lenalidomide-refractory multiple myeloma after 1-3 lines of therapy |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 1063 |
| Language: | English |
| ACCESSION: | WOS:001159306704087 |
| DOI: | 10.1182/blood-2023-178798 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
